News

Actavis’ chairman Bjorgolfur Thor Bjorgolfsson is making the bid through investment vehicle Novator and is offering E0.98 per class A share, valuing the company at E3.3 billion, or

According to the company, the clinical trial is designed to determine therapeutic dosing and evaluate the safety and efficacy of Azedra, a targeted radiotherapeutic, which consists of the

The agreement provides for Gene Logic to receive success-based milestone payments for each drug candidate Abbott returns to clinical development. In addition, Gene Logic will receive royalties for

The US-based pharmaceutical company said that the common obesity clinical trial will look at the effects of Oleoyl-estrone (OE) in 100 patients with a body mass index (BMI)

Primary liver cancer is one of the most commonly occurring cancers in the world. The study will take place at five major US liver cancer treatment centers including

Gardasil protects against the four strains of human papillomavirus that cause 70% of cervical cancer cases. After three years of follow up in two large phase III clinical

The Huntington’s disease (HD) study involved high-tech screening of the human genome and proteome, and was unprecedented both in terms of its scale and in the way the

University of Alberta professor Dr John Greer has demonstrated in both in vitro and in vivo animal models that selected Ampakine compounds can enhance respiratory drive and breathing

The once-daily transdermal patch Neupro will be available in the US in three strengths (2mg/24 hours; 4mg/24 hours; and 6mg/24 hours). Neupro contains rotigotine, which is designed to